[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Infertility Treatment Market - Global Outlook and Forecast 2019-2024

January 2020 | 327 pages | ID: IA97001D5542EN
Arizton Advisory & Intelligence

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The infertility treatment market is expected to grow at a CAGR of over 6% during the forecast period 2018–2024.

The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, obesity, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide.

The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market. The globalization of healthcare facilities and the increasing popularity of medical tourism, especially fertility tourism, encourage several couples to travel abroad to seek state-of-the-art medical care options. The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs

The following factors are likely to contribute to the growth of the infertility treatment market during the forecast period:
  • Increasing Prevalence of Infertility
  • Growing Number of Obesity Cases
  • Increasing Number of Facilities offering Fertility Services
  • Increasing Financial Assistance Programs
  • Growing popularity for Fertility Tourism
The study considers the present scenario of the global infertility treatment market and its market dynamics for the period 2018?2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Infertility Treatment Market: Segmentation

This research report includes detailed segmentation by product, procedure, end-user, cause, and geography. Treatment by drugs has been dominating the infertility treatment market because it is a cost-effective measure and is considered to be the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly and is likely to witness steady growth during the forecast period. However, the surge in the prevalence of sterility, advances IVF devices technology, the increasing trend of delayed pregnancies, and the growth in disposable income are the major factors driving the infertility treatment devices market. Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing due to the increasing effectiveness of ART procedures and surgical interventions that create huge demand for consumables and is expected to grow by 2024.

The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to a high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication. ART is the fastest growing procedure on account of the high acceptance of this treatment because of the improvement in success rate and advanced techniques to cure sterility. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.

The fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility services is expanding across the globe. These clinics occupy the largest share in the infertility treatment market owing to the availability and accessibility of different services such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period due to the constant rise in clinics and increasing partnerships of clinics with fertile consultants and experts.

The female infertility segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing number of dedicated fertility clinics are the major factors driving the growth of the segment. The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns, an increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.

Market Segmentation by Product
  • Drugs
    • Gonadotropins
    • Other Drugs
  • Devices
    • Equipment
    • Media
    • Consumables
Market Segmentation by Procedure
  • Drug Therapy
  • ART Procedure
  • Surgical Intervention
Market Segmentation by End-user
  • Infertility Clinics
  • Hospitals
  • Gynecological & Urology Clinics
  • Others
Market Segmentation by Cause
  • Female Infertility
  • Male Infertility
  • Others
Insights by Geography

Europe is the major region, which is leading the market and is expected to bolster its dominance during the forecast period because the region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. The demand for fertility services is increasing rapidly in North America due to the growing prevalence of sterility, the presence of the aging population and the high occurrence of obesity. These factors are likely to generate significant demand for fertility services in the future. APAC is growing at a steady pace owing to the shifting mean age among women during their first childbirth and the increasing sterility among people in developing countries. Latin America is witnessing a rise in sterility among men and women and decreasing fertility rates in the population, which is likely to increase the demand for fertility services. MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, with the growing awareness and development of advanced technology, the region is expected to drive the infertility treatment market in the region.

Market Segmentation by Geography
  • Europe
    • Spain
    • France
    • Germany
    • UK
    • Italy
  • North America
    • Canada
    • US
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • MEA
    • Turkey
    • Israel
Insights by Vendors

There are a few global and several local and regional vendors offering medicines, devices, and equipment for treatment. The fertility drugs market is highly concentrated with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented with many local and domestic companies are offering a wide array of low-cost drugs in their respective countries. The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.

Key Vendors
  • The Cooper Companies
  • Cook Medical
  • Vitrolife
  • Ferring Pharmaceuticals
  • IVFtech
  • Irvine Scientific
  • Merck KGaA
Other Vendors
  • Abbott
  • Sanofi
  • Salix Pharmaceuticals
  • Microtech IVF
  • Novartis
  • Hamilton Thorne
  • The Merck Co
  • Thermo Fisher Scientific
  • INVO Bioscience
  • MedGyn Products
  • SOMATEX Medical Technologies
  • CARL ZEISS
Key Market Insights

The analysis of the infertility treatment market provides sizing and growth opportunities for the forecast period 2019–2024.
  • Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
  • Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
  • Delivers a complete overview of segments and the regional outlook of the infertility treatment market.
  • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.
1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 Market Definition
  4.1.1 Inclusions
  4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
  4.4.1 Market Segmentation by Products
  4.4.2 Market Segmentation by Infertility Cause
  4.4.3 Market Segmentation by Procedure
  4.4.4 Market Segmentation by End-users
  4.4.5 Market Segmentation by Geography

5 REPORT ASSUMPTIONS & CAVEATS

5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 Infertility: An Overview
  7.1.1 Symptoms of Infertility
  7.1.2 Causes of Infertility
  7.1.3 Infertility Treatment
7.2 Infertility Treatment: Global Market Snapshot
  7.2.1 Overview

8 MARKET DYNAMICS

8.1 Market Growth Enablers
  8.1.1 Increasing Prevalence of Infertility
  8.1.2 Rising Number of Obesity Cases
  8.1.3 Increasing Acceptance of ART Procedures
  8.1.4 Increasing Number of Facilities Offering Fertility Services
8.2 Market Growth Restraints
  8.2.1 High Cost of Infertility Treatment
  8.2.2 Lack of Standardized Government Regulations on Infertility Treatment
  8.2.3 Ethical Challenges Related to Infertility Treatment
  8.2.4 Limitations & Risks Associated with Infertility Treatment
8.3 Market Opportunities & Trends
  8.3.1 Financial Assistance Programs & Employer Benefits for Infertility Treatment
  8.3.2 Growing Popularity of Fertility/Reproductive Tourism
  8.3.3 Technological Advancements & Innovations
  8.3.4 Acceptance of Infertility Treatment in Single Parents & Same-Sex Couples

9 GLOBAL INFERTILITY TREATMENT MARKET

9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
  9.3.1 Threat of New Entrants
  9.3.2 Bargaining Power of Suppliers
  9.3.3 Bargaining Power of Buyers
  9.3.4 Threat of Substitutes
  9.3.5 Competitive Rivalry

10 BY PRODUCT

10.1 Market Snapshot & Growth Engine
10.2 Market Overview

11 INFERTILITY TREATMENT BY DRUGS

11.1 Market Overview
  11.1.1 Market Size & Forecast
11.2 Gonadotropins
  11.2.1 Market Overview
  11.2.2 Market Size & Forecast
11.3 Other Drugs
  11.3.1 Market Overview
  11.3.2 Market Size & Forecast
11.4 Infertility Drugs: Market Segmentation by Region
  11.4.1 Overview

12 INFERTILITY TREATMENT BY DEVICES

12.1 Market Overview
  12.1.1 Market Size & Forecast
12.2 Equipment
  12.2.1 Market Overview
  12.2.2 Market Size & Forecast
12.3 Media
  12.3.1 Market Overview
  12.3.2 Market Size & Forecast
12.4 Consumables & Accessories
  12.4.1 Market Overview
  12.4.2 Market Size & Forecast
12.5 Infertility Treatment Devices: Segmentation by Region
  12.5.1 Overview

13 BY CAUSE

13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Female Infertility
  13.3.1 Market Overview
  13.3.2 Market Size & Forecast
13.4 Male Infertility
  13.4.1 Market Overview
  13.4.2 Market Size & Forecast
13.5 Other Types of Infertility
  13.5.1 Market Overview
  13.5.2 Market Size & Forecast

14 BY PROCEDURE

14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Medication
  14.3.1 Market Overview
  14.3.2 Market Size & Forecast
14.4 Assisted Reproductive Treatment
  14.4.1 Market Overview
  14.4.2 Market Size & Forecast
14.5 Surgical Intervention
  14.5.1 Market Overview
  14.5.2 Market Size & Forecast

15 BY END-USER

15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Fertility Clinics
  15.3.1 Market Overview
  15.3.2 Market Size & Forecast
15.4 Hospitals
  15.4.1 Market Overview
  15.4.2 Market Size & Forecast
15.5 Gynecology & Urology Clinics
  15.5.1 Market Overview
  15.5.2 Market Size & Forecast
15.6 Other End-users
  15.6.1 Market Overview
  15.6.2 Market Size & Forecast

16 BY GEOGRAPHY

16.1 Market Snapshot & Growth Engine
16.2 Market Overview

17 EUROPE

17.1 Market Overview
17.2 Market Size & Forecast
17.3 Market Segmentation by Product Type
  17.3.1 Overview
17.4 Key Countries
  17.4.1 Spain: Market Size & Forecast
  17.4.2 France: Market Size & Forecast
  17.4.3 Germany: Market Size & Forecast
  17.4.4 UK: Market Size & Forecast
  17.4.5 Italy: Market Size & Forecast

18 NORTH AMERICA

18.1 Market Overview
18.2 Market Size & Forecast
18.3 Market Segmentation by Product Type
  18.3.1 Overview
18.4 Key Countries
  18.4.1 US: Market Size & Forecast
  18.4.2 Canada: Market Size & Forecast

19 APAC

19.1 Market Overview
19.2 Market Size & Forecast
19.3 Market Segmentation by Product Type
  19.3.1 Overview
19.4 Key Countries
  19.4.1 Japan: Market Size & Forecast
  19.4.2 Australia: Market Size & Forecast
  19.4.3 China: Market Size & Forecast
  19.4.4 India: Market Size & Forecast

20 LATIN AMERICA

20.1 Market Overview
20.2 Market Size & Forecast
20.3 Market Segmentation by Product Type
  20.3.1 Overview
20.4 Key Countries
  20.4.1 Brazil: Market Size & Forecast
  20.4.2 Argentina: Market Size & Forecast
  20.4.3 Mexico: Market Size & Forecast

21 MIDDLE EAST & AFRICA

21.1 Market Overview
21.2 Market Size & Forecast
21.3 Market Segmentation by Product Type
  21.3.1 Overview
21.4 Key Countries
  21.4.1 Turkey: Market Size & Forecast
  21.4.2 Israel: Market Size & Forecast

22 COMPETITIVE LANDSCAPE

22.1 Competition Overview
22.2 Vendors Market Share Analysis
  22.2.1 The Cooper Companies
  22.2.2 Cook Medical
  22.2.3 Vitrolife in Infertility Treatment Market
  22.2.4 Ferring Pharmaceuticals
  22.2.5 Merck KGaA
  22.2.6 IVFtech in Infertility Treatment Market

23 KEY COMPANY PROFILES

23.1 The Cooper Companies
  23.1.1 Business Overview
  23.1.2 Major Product Offerings
  23.1.3 Key Strengths
  23.1.4 Key Strategies
  23.1.5 Key Opportunities
23.2 Cook Medical
  23.2.1 Business Overview
  23.2.2 Major Product Offerings
  23.2.3 Key Strengths
  23.2.4 Key Strategies
  23.2.5 Key Opportunities
23.3 Vitrolife
  23.3.1 Business Overview
23.4 Major Product Offerings
  23.4.1 Key Strengths
  23.4.2 Key Strategies
  23.4.3 Key Opportunities
23.5 Ferring Pharmaceuticals
  23.5.1 Business Overview
  23.5.2 Major Product Offerings
  23.5.3 Key Strengths
  23.5.4 Key Strategies
  23.5.5 Key Opportunities
23.6 IVFtech
  23.6.1 Business Overview
  23.6.2 Major Product Offerings
  23.6.3 Key Strengths
  23.6.4 Key Strategies
  23.6.5 Key Opportunities
23.7 FUJIFILM Irvine Scientific
  23.7.1 Business Overview
  23.7.2 Major Product Offerings
  23.7.3 Key Strengths
  23.7.4 Key Strategies
  23.7.5 Key Opportunities
23.8 Merck KGaA
  23.8.1 Business Overview
  23.8.2 Major Product Offerings
  23.8.3 Key Strengths
  23.8.4 Key Strategies
  23.8.5 Key Opportunities

24 OTHER PROMINENT VENDORS

24.1 Abbott
  24.1.1 Business Overview
  24.1.2 Major Product Offerings
24.2 Sanofi
  24.2.1 Business Overview
  24.2.2 Major Product Offerings
24.3 Salix Pharmaceuticals
  24.3.1 Business Overview
  24.3.2 Major Product Offerings
24.4 Microtech IVF
  24.4.1 Business Overview
  24.4.2 Major Product Offering
24.5 Novartis
  24.5.1 Business Overview
  24.5.2 Major Product Offerings
24.6 Hamilton Thorne
  24.6.1 Business Overview
  24.6.2 Major Product Offering
24.7 Merck Co
  24.7.1 Business Overview
  24.7.2 Major Product Offerings
24.8 Thermo Fisher Scientific
  24.8.1 Business Overview
  24.8.2 Major Product Offerings
24.9 INVO Bioscience
  24.9.1 Business Overview
  24.9.2 Major Product Offerings
24.10 MedGyn Products
  24.10.1 Business Overview
  24.10.2 Major Product Offerings
24.11 SOMATEX Medical Technologies
  24.11.1 Business Overview
  24.11.2 Major Product Offerings
24.12 Carl Zeiss
  24.12.1 Business Overview
  24.12.2 Major Product Offerings

25 REPORT SUMMARY

25.1 Key Takeaways
25.2 Strategic Recommendations
25.3 Quantitative Summary
  25.3.1 By Product
  25.3.2 By Procedure
  25.3.3 By Infertility Cause
  25.3.4 By End-user
  25.3.5 By Geography
  25.3.6 By Drugs
  25.3.7 By Devices

26 APPENDIX

26.1 Abbreviations

LIST OF EXHIBITS

Exhibit 1 Segmentation of Global Infertility Treatment Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 5-year Primary Infertility Rate Among Males & Females
Exhibit 4 5-year Secondary Infertility Rate Among Males & Females
Exhibit 5 Causes of Infertility
Exhibit 6 Global Infertility Treatment Market by Product 2018 (%)
Exhibit 7 Global Infertility Treatment Market by Geography 2018 (%)
Exhibit 8 Impact of Increasing Prevalence of Infertility
Exhibit 9 Couples Affected by Infertility Worldwide from 1990?2010 (million)
Exhibit 10 Six Demographic Realities of Infertility
Exhibit 11 Share of Primary and Secondary Fertility Among Couples Worldwide
Exhibit 12 Cause of Infertility Among Couples by Region 2015 (%)
Exhibit 13 Percentage of Infertile Married Women in US 2002?2015
Exhibit 14 Share of Infertile Women with Infection-related Diagnosis by Region
Exhibit 15 Mean Age of Women Having Their First Child in Developed and Developing Countries
Exhibit 16 Impact of Rising Number of Obesity Cases
Exhibit 17 Number of Obese Adults by Gender 2016 (million)
Exhibit 18 Prevalence Rate of Obesity in Men and Women 2016
Exhibit 19 Worldwide Number of Obese Adults 1975 Versus 2016 (million)
Exhibit 20 Worldwide Prevalence of Obesity Among Adults by Region 2016
Exhibit 21 Impact of Increasing Acceptance of ART Procedures
Exhibit 22 Global Number of ART Cycles Performed 2007 Versus 2018
Exhibit 23 Number of ART Cycles Performed by Region 2018
Exhibit 24 Impact of Increasing Number of Facilities Offering Fertility Services
Exhibit 25 Percentage Share of ART Cycles Performed by Region 2018
Exhibit 26 Share of Stand-alone Fertility Care Centers by Region 2017
Exhibit 27 Impact of High Cost of Infertility Treatment
Exhibit 28 Average Cost of Single IVF Cycle in Various Countries ($)
Exhibit 29 Impact of Lack of Standardized Government Regulations on Infertility Treatment
Exhibit 30 Major Legal Differences Between Countries for Infertility Treatment
Exhibit 31 Impact of Ethical Challenges Related to Infertility Treatment
Exhibit 32 Impact of Limitations & Risks Associated with Infertility Treatment
Exhibit 33 Limitations & Risks Associated with Infertility Treatment
Exhibit 34 Cumulative Pregnancy Rate of IVF Procedure
Exhibit 35 Impact of Financial Assistance Programs & Employer Benefits for Infertility Treatment
Exhibit 36 Impact of Growing Popularity of Fertility/Reproductive Tourism
Exhibit 37 Factors Influencing Patients to Consider Fertility Tourism
Exhibit 38 Impact of Technological Advancements & Innovations
Exhibit 39 Impact of Acceptance of Infertility Treatment in Single Parents & Same-Sex Couples
Exhibit 40 Same-Sex Married Couples in US Between 2004-2014 Period
Exhibit 41 Global Infertility Treatment Market 2018?2024 ($ million)
Exhibit 42 Global Infertility Treatment by Procedure
Exhibit 43 Global Infertility Treatment Market by Product Type
Exhibit 44 Global Infertility Treatment Market by Geography
Exhibit 45 Global Infertility Treatment Market by Cause
Exhibit 46 Global Infertility Market by End-users
Exhibit 47 Five Forces Analysis 2018
Exhibit 48 Incremental Growth by Product 2018–2024
Exhibit 49 Global Infertility Treatment Market by Product
Exhibit 50 Global Infertility Treatment Market by Product 2018?2024 ($ million)
Exhibit 51 Global Infertility Treatment Market by Product 2018?2024 (%)
Exhibit 52 Global Infertility Drugs Treatment Market 2018?2024 ($ million)
Exhibit 53 Global Gonadotropins Market 2018-2024 ($ million)
Exhibit 54 Global Infertility Other Drugs Treatment Market 2018-2024 ($ million)
Exhibit 55 Global Infertility Drugs Market by Region 2018 & 2024 (%)
Exhibit 56 Global Infertility Drugs Market by Region 2018-2024 ($ million)
Exhibit 57 Global Infertility Drugs Market by Region 2018-2024 (%)
Exhibit 58 Global Infertility Devices Market 2018?2024 ($ million)
Exhibit 59 Global Infertility Equipment Market 2018-2024 ($ million)
Exhibit 60 Global Infertility Treatment Media Market 2018-2024 ($ million)
Exhibit 61 Global Infertility Treatment Consumables & Accessories Market 2018-2024 ($ million)
Exhibit 62 Global Infertility Devices Market by Region 2018 & 2024 (%)
Exhibit 63 Global Infertility Devices Market by Region 2018-2024 ($ million)
Exhibit 64 Global Infertility Devices Market by Region 2018-2024 (%)
Exhibit 65 Incremental Growth by Cause 2018-2024
Exhibit 66 Global Infertility Treatment Market by Cause
Exhibit 67 Global Infertility Treatment Market by Cause 2018 & 2024 (%)
Exhibit 68 Global Infertility Treatment Market by Cause 2018?2024 ($ million)
Exhibit 69 Global Infertility Treatment Market by Cause 2018?2024 (%)
Exhibit 70 5-year Female Factor Contribution to Primary Infertility Cases
Exhibit 71 Global Female Infertility Treatment Market 2018?2024 ($ million)
Exhibit 72 5-year Female Factor Contribution to Secondary Infertility Cases
Exhibit 73 5-year Male Factor Contribution to Primary Infertility Cases
Exhibit 74 Percentage Share of Major Causes of Male Infertility
Exhibit 75 5-year Male Factor Contribution to Secondary Infertility Cases
Exhibit 76 Global Male Infertility Treatment Market 2018?2024 ($ million)
Exhibit 77 Global Other Infertility Treatment Market 2018?2024 ($ million)
Exhibit 78 Percentage Share of Couples Reported Infertile by Region
Exhibit 79 Incremental Growth by Procedure 2018?2024
Exhibit 80 Global Infertility Treatment Market by Procedure
Exhibit 81 Global Infertility Treatment Market by Procedure 2018 & 2024 (%)
Exhibit 82 Global Infertility Treatment Market by Procedure 2018?2024 ($ million)
Exhibit 83 Global Infertility Treatment Market by Procedure 2018?2024 (%)
Exhibit 84 Global Infertility Medication Market 2018?2024 ($ million)
Exhibit 85 Adults with Obesity Worldwide
Exhibit 86 Cost Comparison of IVF and Surrogacy
Exhibit 87 Global ART Infertility Treatment Market 2018?2024 ($ million)
Exhibit 88 Global Infertility Surgical Intervention Market 2018?2024 ($ million)
Exhibit 89 Incremental Growth by End-users 2018?2024
Exhibit 90 Global Infertility Treatment Market by End-user
Exhibit 91 Global Infertility Treatment Market by End-user 2018 & 2024 (%)
Exhibit 92 Global Infertility Treatment Market by End-user 2018?2024 ($ million)
Exhibit 93 Global Infertility Treatment Market by End-user 2018?2024 (%)
Exhibit 94 Global Fertility Clinics Market 2018?2024 ($ million)
Exhibit 95 Global Infertility Treatment Hospitals Market 2018?2024 ($ million)
Exhibit 96 Global Infertility Gynecology Clinic Market 2018?2024 ($ million)
Exhibit 97 Global Other Infertility Treatment Market 2018?2024 ($ million)
Exhibit 98 Incremental Growth by Geography 2018?2024
Exhibit 99 Global Infertility Treatment Market by Region
Exhibit 100 Global Infertility Treatment Market by Region 2018 & 2024 (%)
Exhibit 101 Global Infertility Treatment Market by Region 2018?2024 ($ million)
Exhibit 102 Global Infertility Treatment Market by Region 2018?2024 (%)
Exhibit 103 Infertility Treatment Market in Europe: Key Countries Share 2018 (%)
Exhibit 104 Percentage Share of Certified IVF & Fertility Clinics by Region 2018
Exhibit 105 Infertility Treatment Market in Europe 2018–2024 ($ million)
Exhibit 106 Infertility Treatment Market in Europe by Product 2018 & 2024 (%)
Exhibit 107 Infertility Treatment Market in Europe by Product 2018-2024 (%)
Exhibit 108 Infertility Treatment Market in Europe by Product 2018-2024 (%)
Exhibit 109 Incremental Growth in Europe 2018?2024
Exhibit 110 Infertility Treatment Market in Spain 2018–2024 ($ million)
Exhibit 111 Infertility Treatment Market in France 2018–2024 ($ million)
Exhibit 112 Infertility Treatment Market in Germany 2018–2024 ($ million)
Exhibit 113 Infertility Treatment Market in UK 2018–2024 ($ million)
Exhibit 114 Infertility Treatment Market in Italy 2018–2024 ($ million)
Exhibit 115 Infertility Treatment Market in North America: Key Countries Share 2018 (%)
Exhibit 116 Percentage Share of ART Cycles Performed in North America by Countries 2018
Exhibit 117 Infertility Rate Among Women Based on Age in North America 2018 (%)
Exhibit 118 Percentage of Infertile Married Women in 15?44 Age Group
Exhibit 119 Infertility Treatment Market in North America 2018–2024 ($ million)
Exhibit 120 Infertility Treatment Market in North America by Product 2018 & 2024 (%)
Exhibit 121 Infertility Treatment Market in North America by Product 2018-2024 (%)
Exhibit 122 Infertility Treatment Market in North America by Product 2018-2024 (%)
Exhibit 123 Incremental Growth in North America 2018?2024
Exhibit 124 Share of Adult People with Obesity in US 2012
Exhibit 125 Estimated Share of Adult People with Obesity in US 2030
Exhibit 126 Infertility Treatment Market in US 2018–2024 ($ million)
Exhibit 127 Number of Infants Born and ART Procedures Performed in US (2002?2012)
Exhibit 128 Percentage Share of ART Cycles Based on Age Group 2018 (%)
Exhibit 129 Infertility Treatment Market in Canada 2018–2024 ($ million)
Exhibit 130 Infertility Treatment Market in APAC: Key Countries Share 2018 (%)
Exhibit 131 Percentage Share of ARTs Performed in Various Regions
Exhibit 132 Infertility Treatment Market in APAC 2018–2024 ($ million)
Exhibit 133 Infertility Treatment Market in APAC by Product 2018 & 2024 (%)
Exhibit 134 Infertility Treatment Market in APAC by Product 2018-2024 (%)
Exhibit 135 Infertility Treatment Market in APAC by Product 2018-2024 ($million)
Exhibit 136 Incremental Growth in APAC 2018?2024
Exhibit 137 Infertility Treatment Market in Japan 2018–2024 ($ million)
Exhibit 138 Infertility Treatment Market in Australia 2018–2024 ($ million)
Exhibit 139 Infertility Treatment Market in China 2018–2024 ($ million)
Exhibit 140 Infertility Treatment Market in India 2018–2024 ($ million)
Exhibit 141 Infertility Treatment Market in Latin America: Key Countries Share 2018 (%)
Exhibit 142 Lifetime Births Per Women in Key Latin American Countries
Exhibit 143 Infertility Treatment Market in Latin America 2018–2024 ($ million)
Exhibit 144 Infertility Treatment Market in Latin America by Product 2018 & 2024 (%)
Exhibit 145 Infertility Treatment Market in Latin America by Product 2018-2024 ($million)
Exhibit 146 Infertility Treatment Market in Latin America by Product 2018-2024 (%)
Exhibit 147 Incremental Growth in Latin America 2018?2024
Exhibit 148 Infertility Treatment Market in Brazil 2018–2024 ($ million)
Exhibit 149 Infertility Treatment Market in Argentina 2018–2024 ($ million)
Exhibit 150 Infertility Treatment Market in Mexico 2018–2024 ($ million)
Exhibit 151 Infertility Treatment Market in MEA: Key Countries Share 2018 (%)
Exhibit 152 Infertility Treatment Market in MEA 2018–2024 ($ million)
Exhibit 153 Infertility Treatment Market in MEA by Product 2018 & 2024 (%)
Exhibit 154 Infertility Treatment Market in MEA by Product 2018-2024 ($ million)
Exhibit 155 Infertility Treatment Market in MEA by Product 2018-2024 (%)
Exhibit 156 Incremental Growth in MEA 2018?2024
Exhibit 157 Infertility Treatment Market in Turkey 2018–2024 ($ million)
Exhibit 158 Infertility Treatment Market in Israel 2018–2024 ($ million)
Exhibit 159 CooperSurgical Revenue Breakdown by category FY2018 (%)
Exhibit 160 Vitrolife Sales Breakdown by Business Segment 2018
Exhibit 161 Merck KGaA Fertility Product Line Revenue 2018 & 2017 ($ million)
Exhibit 162 The Cooper Companies Sales Revenue 2018-2016 ($ million)
Exhibit 163 The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 164 The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 165 The Cooper Companies R&D Expenditure 2016-2018 ($ million)
Exhibit 166 Vitrolife Sales Revenue 2018–2016 ($ million)
Exhibit 167 Vitrolife Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 168 Vitrolife Sales Breakdown by Business Segment 2018
Exhibit 169 Vitrolife Sales Breakdown by Geography 2018
Exhibit 170 Merck KGaA Sales Revenue 2016?2018 ($ million)
Exhibit 171 Merck KGaA Sales Revenue by Business Segments 2018 & 2017 ($ million)
Exhibit 172 Merck KGaA Sales Breakdown by Business Segment 2018
Exhibit 173 Merck KGaA Sales Breakdown by Geography 2018

LIST OF TABLES

Table 1 Key Caveats
Table 2 Currency Conversion 2013?2018
Table 3 Effects of Adipokines on Reproduction
Table 4 Chances of a Live Birth by Fifth IVF Cycle
Table 5 Cost of Various Infertility Treatment Options
Table 6 Estimated Cost of IVF Treatment in Various Countries
Table 7 Ethical and Legal Challenges Prevailing in Various Countries
Table 8 Pregnancy Rate Among Women Undergoing IVF
Table 9 Pregnancy Rate Among Women Undergoing ICSI
Table 10 Pregnancy Rate Among Women Donor Eggs & Embryos
Table 11 Financial Assistance Programs for Infertility Treatment
Table 12 Major Destinations for Fertility Tourism
Table 13 New Developments/Advancements in Infertility Treatment
Table 14 List of Major Countries Allowing Same-sex Marriage
Table 15 Available Treatment Options for Single Women to Conceive
Table 16 Popular Infertility Treatment Drugs Commercially Available
Table 17 Different Types of Microscopes used in ART Procedures
Table 18 Different Types of Imaging Modalities Used in ART Procedures
Table 19 Mean Age of Women at First Birth by Key Countries
Table 20 Major Drugs Prescribed for Infertility
Table 21 Global List of Popular Fertility Clinics
Table 22 List of Popular Cryobanks Offering Storage of Sperms, Eggs, and Embryos
Table 23 Competitive Structure Analysis of Global Infertility Treatment Market 2018
Table 24 Global Infertility Treatment Market by Drugs: Key Vendors Ranking 2018
Table 25 Global Infertility Treatment Market by Devices: Key Vendors Ranking 2018
Table 26 The Cooper Companies: Product Offerings
Table 27 Cook Medical: Fields of Applications
Table 28 Cook Medical: Product Offerings
Table 29 Vitrolife: Product Offerings
Table 30 Ferring Pharmaceuticals: Product Offerings
Table 31 IVFtech: Product Offerings
Table 32 FUJIFILM Irvine Scientific: Product Offerings
Table 33 Merck KGaA: Product Offerings
Table 34 Abbott: Key Product Offerings
Table 35 Sanofi: Key Product Offerings
Table 36 Salix Pharmaceuticals: Key Product Offerings
Table 37 Microtech IVF: Key Product Offerings
Table 38 Novartis: Key Product Offerings
Table 39 Hamilton Thorne: Key Product Offerings
Table 40 Merck Co: Key Product Offerings
Table 41 Thermo Fisher Scientific: Key Product Offerings
Table 42 INVO Bioscience: Key Product Offerings
Table 43 MedGyn Products: Key Product Offerings
Table 44 SOMATEX Medical Technologies: Key Product Offerings
Table 45 CARL ZEISS: Key Product Offerings
Table 46 Global Infertility Treatment Market by Products ($ million)
Table 47 Global Infertility Treatment Market by Products (%)
Table 48 Global Infertility Treatment Market by Procedure ($ million)
Table 49 Global Infertility Treatment Market by Applications (%)
Table 50 Global Infertility Treatment Market by Cause ($ million)
Table 51 Global Infertility Treatment Market by Cause (%)
Table 52 Global Infertility Treatment Market by End-users ($ million)
Table 53 Global Infertility Treatment Market by End-users (%)
Table 54 Global Infertility Treatment Market by Geography ($ million)
Table 55 Global Infertility Treatment Market by Geography (%)
Table 56 Global Infertility Treatment Market by Drugs ($ million)
Table 57 Global Infertility Treatment Market by Drugs (%)
Table 58 Global Infertility Treatment Market by Devices ($ million)
Table 59 Global Infertility Treatment Market by Devices (%)


More Publications